Near infrared fluorescence imaging of EGFR expressionin vivousing IRDye800CW-nimotuzumab
Open Access
- 21 December 2017
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 9 (5) , 6213-6227
Abstract
Near infrared fluorescence imaging of EGFR expression in vivo using IRDye800CW-nimotuzumab Near infrared fluorescence imaging of EGFR expression in vivo using IRDye800CW-nimotuzumabKeywords
This publication has 31 references indexed in Scilit:
- Preclinical evaluation of near‐infrared (NIR) fluorescently labeled cetuximab as a potential tool for fluorescence‐guided surgeryInternational Journal of Cancer, 2016
- Epidermal growth factor receptor targeting in cancer: A review of trends and strategiesBiomaterials, 2013
- Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human resultsNature Medicine, 2011
- Immunohistochemical expression of epidermal growth factor receptor, E-cadherin, and matrix metalloproteinase–9 in ovarian epithelial cancer and relation to patient deathsAnnals of Diagnostic Pathology, 2010
- Obtaining Adequate Surgical Margins in Breast-Conserving Therapy for Patients with Early-Stage Breast Cancer: Current Modalities and Future DirectionsAnnals of Surgical Oncology, 2009
- Overexpression of epidermal growth factor type-1 receptor (EGF-R1) in cervical cancer: Implications for Cetuximab-mediated therapy in recurrent/metastatic diseaseGynecologic Oncology, 2007
- Quantitative Measurement of Epidermal Growth Factor Receptor Is a Negative Predictive Factor for Tamoxifen Response in Hormone Receptor–Positive Premenopausal Breast CancerJournal of Clinical Oncology, 2007
- Increased Epidermal Growth Factor Receptor Gene Copy Number Is Associated With Poor Prognosis in Head and Neck Squamous Cell CarcinomasJournal of Clinical Oncology, 2006
- Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal CancerNew England Journal of Medicine, 2004
- The protein tyrosine kinase family of the human genomeOncogene, 2000